Hermitte L, Vialettes B, Naquet P, Atlan C, Payan M J, Vague P
Laboratory of Diabetology, University of Marseille, Marseille-Luminy, France.
Eur J Immunol. 1990 Jun;20(6):1297-303. doi: 10.1002/eji.1830200615.
In order to gain insight into the interaction between autoimmunity and viral infection in the onset of insulin-dependent diabetes, non-obese diabetic (NOD) mice which spontaneously develop autoimmune diabetes were inoculated with the diabetogenic variant of the encephalomyocarditis virus (EMCV-D) before the onset of the disease. The pre-diabetic period was divided into two phases: the early phase (days 88 to 116) during which development of spontaneous diabetes is rare and the late phase (day 123 to 200) during which the incidence of spontaneous diabetes is high. As controls ICR mice of common ancestry were also inoculated. During the early phase diabetes was observed in 4/10 inoculated, 0/13 control NOD and 7/13 inoculated ICR males vs. 6/12 inoculated, 1/11 control NOD and 0/15 inoculated ICR females. However, in NOD female, virus-induced diabetes prevalence was variable from one experiment to another. In parallel the flow cytometric analysis showed a high percentage of L3T4+ T lymphocytes in the pancreas of inoculated female NOD mice 10 days after the infection. At this time a large proportion of both L3T4+ and Ly-2+ cells expressed the interleukin 2 receptor. During the late phase no new case of diabetes occurred in inoculated NOD mice but one case was observed in control NOD males and five in control NOD females. This prevention of autoimmune diabetes was constantly found in other experiments. Insulitis was milder in inoculated NOD mice of both sexes than in control NOD. Adoptive transfer of diabetes into irradiated 8-week-old males by splenocytes from 28-week-old females was successful in five out seven attempts with control splenocytes and in zero out of six attempts with splenocytes from inoculated mice. This immunosuppression was specific as the ability of lymphocytes to respond to soluble or allogeneic antigens was preserved. In the early phase EMCV-D precipitated the onset of diabetes in females NOD mice by amplifying L3T4+ T lymphocyte-mediated immune mechanisms. During the late phase viral infection had lessened immune processes in animals which had resisted or recovered from virus-induced diabetes.
为深入了解自身免疫与病毒感染在胰岛素依赖型糖尿病发病过程中的相互作用,在疾病发作前,给自发发生自身免疫性糖尿病的非肥胖糖尿病(NOD)小鼠接种脑心肌炎病毒致糖尿病变体(EMCV-D)。糖尿病前期分为两个阶段:早期阶段(第88至116天),此阶段自发糖尿病的发生率较低;晚期阶段(第123至200天),此阶段自发糖尿病的发生率较高。作为对照,也给具有共同祖先的ICR小鼠接种。在早期阶段,接种的10只NOD雄性小鼠中有4只出现糖尿病,13只对照NOD雄性小鼠中无发病,13只接种的ICR雄性小鼠中有7只发病;接种的12只NOD雌性小鼠中有6只发病,11只对照NOD雌性小鼠中有1只发病,15只接种的ICR雌性小鼠中无发病。然而,在NOD雌性小鼠中,病毒诱导的糖尿病患病率在不同实验中有所不同。同时,流式细胞术分析显示,感染后10天,接种的雌性NOD小鼠胰腺中L3T4 + T淋巴细胞的比例较高。此时,L3T4 +和Ly-2 +细胞中有很大一部分表达白细胞介素2受体。在晚期阶段,接种的NOD小鼠未出现新的糖尿病病例,但对照NOD雄性小鼠中有1例发病,对照NOD雌性小鼠中有5例发病。在其他实验中也经常发现这种对自身免疫性糖尿病的预防作用。接种的NOD雌雄小鼠的胰岛炎均比对照NOD小鼠轻。用28周龄雌性小鼠的脾细胞将糖尿病过继转移到8周龄受辐照雄性小鼠中,使用对照脾细胞的7次尝试中有5次成功,而使用接种小鼠脾细胞的6次尝试均未成功。这种免疫抑制具有特异性,因为淋巴细胞对可溶性或同种异体抗原的反应能力得以保留。在早期阶段,EMCV-D通过放大L3T4 + T淋巴细胞介导的免疫机制,促使雌性NOD小鼠糖尿病发病。在晚期阶段,病毒感染减轻了那些已抵抗病毒诱导的糖尿病或从中恢复的动物的免疫过程。